COMMUNIQUÉS West-GlobeNewswire
-
Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio
01/04/2026 -
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
01/04/2026 -
Noom Acquires Licensed 503A Pharmacy, Accelerating the Next Era of Preventive Care and Enabling Noom’s Expansion Beyond Weight Health
01/04/2026 -
Femasys Appoints John Canning as Chief Operating Officer to Drive Operational Execution and Advance Commercial Growth
01/04/2026 -
Lumina Therapy Alliance Expands to the Bay Area with Addition of San Francisco Stress and Anxiety Center, Approaching 400 Clinicians Nationwide
01/04/2026 -
Oncolytics Biotech® Completes Domicile Change to the United States
01/04/2026 -
NurExone Receives First Place in Healthcare at BOLD Awards VII and Engages Investor Brand Network to Support Awareness Strategy
01/04/2026 -
Roto-Rooter Completes Acquisitions for Two Significant Territories
01/04/2026 -
From The Earth and Illicit Launch Golden Ticket Giveaway This 4/20 Weekend
01/04/2026 -
Extendicare Acquires CBI Home Health
01/04/2026 -
Soleo Health Selected as an Authorized Specialty Pharmacy of QIVIGY® For Primary Humoral Immunodeficiency (PI) Treatment
01/04/2026 -
FeraMAX est le supplemént de fer le plus recommandé au Canada depuis 11 années consécutives
01/04/2026 -
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Virginia based Industrial Manufacturing Client
01/04/2026 -
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development
01/04/2026 -
Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting
01/04/2026 -
Johns Hopkins Health Plans Sits Down with Dundalk Seniors to Champion Community Connection
01/04/2026 -
OneMedNet, Onco-Innovations and Inka Health Announces Collaboration Aimed to Accelerate Potential for Oncology Drug Development Using Real-World Data and AI
01/04/2026 -
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
01/04/2026 -
Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year
01/04/2026
Pages